tm logo
MODES
Live/Registered
REGISTERED

on 24 Oct 2023

Last Applicant/ Owned by

Ritter House, P.O. Box 173

Road Town, Tortola

VG

VG1110

Serial Number

90980437 filed on 14th Apr 2021

Registration Number

7202731 registered on 24th Oct 2023

in the Principal Register

Correspondent Address

Monica Riva Talley

STERNE KESSLER GOLDSTEIN & FOX PLLC

1100 NEW YORK AVE NW, SUITE 600

WASHINGTON, DC 20005

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

MODES

Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders


First Use Date in General

06th Mar 2023

First Use Date in Commerce

06th Mar 2023

Mark Details


Serial Number

No 90980437

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 4501.0710000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
24th Oct 2023REGISTERED-PRINCIPAL REGISTER
24th Oct 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
19th Sep 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
18th Sep 2023DIVISIONAL PROCESSING COMPLETE
18th Sep 2023STATEMENT OF USE PROCESSING COMPLETE
18th Sep 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15th Sep 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
07th Sep 2023TEAS STATEMENT OF USE RECEIVED
07th Sep 2023TEAS REQUEST TO DIVIDE RECEIVED
07th Sep 2023DIVISIONAL REQUEST RECEIVED